Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Jump to: Article | Conference item
Number of items: 134.
Article
(2021)
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
The Lancet Respiratory Medicine
10.1016/s2213-2600(21)00435-5.
(In press).
|
 |
|
100,000 Genomes Project Pilot Investigators;
Smedley, D;
Smith, KR;
Martin, A;
Thomas, EA;
McDonagh, EM;
Cipriani, V;
... Caulfield, M; + view all
(2021)
100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report.
New England Journal of Medicine
, 385
(20)
pp. 1868-1880.
10.1056/NEJMoa2035790.
|
|
Abani, O;
Abbas, A;
Abbas, F;
Abbas, M;
Abbasi, S;
Abbass, H;
Abbott, A;
... et alia, .; + view all
(2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
The Lancet
, 397
(10285)
pp. 1637-1645.
10.1016/S0140-6736(21)00676-0.
|
|
|
Altmann, DM;
Boyton, RJ;
Beale, R;
(2021)
Immunity to SARS-CoV-2 variants of concern.
Science
, 371
(6534)
pp. 1103-1104.
10.1126/science.abg7404.
|
|
|
Anandh, U;
Gowrishankar, S;
Sharma, A;
Salama, A;
Dasgupta, I;
(2021)
Kidney transplant dysfunction in a patient with COVID - 19 infection: role of concurrent Sars-Cov 2 nephropathy, chronic rejection and vitamin C-mediated hyperoxalosis: case report.
BMC Nephrology
, 22
(1)
, Article 91. 10.1186/s12882-021-02298-x.
|
|
|
Antonelou, M;
Abro, A;
Heath, R;
Iacovou, A;
Ashley, C;
Caplan, J;
Morgan, MD;
... Salama, AD; + view all
(2021)
Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis.
Scandinavian Journal of Rheumatology
10.1080/03009742.2021.1926318.
|
|
|
Balestrini, S;
Koepp, MJ;
Gandhi, S;
Rickman, HM;
Yen Shin, G;
Houlihan, CF;
Anders-Cannon, J;
... Sisodiya, SM; + view all
(2021)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
Epilepsy & Behavior
, 115
, Article 107602. 10.1016/j.yebeh.2020.107602.
|
|
Bassanese, G;
Wlodkowski, T;
Servais, A;
Heidet, L;
Roccatello, D;
Emma, F;
Levtchenko, E;
... Schaefer, F; + view all
(2021)
The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results.
Orphanet Journal of Rare Diseases
, 16
(1)
, Article 251. 10.1186/s13023-021-01872-8.
|
|
|
Bianic, F;
Guelfucci, F;
Robin, L;
Martre, C;
Game, D;
Bockenhauer, D;
(2021)
Epidemiology of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data.
Nephron
, 145
pp. 486-495.
10.1159/000516876.
|
|
|
Billany, RE;
Selvaskandan, H;
Adenwalla, SF;
Hull, KL;
March, DS;
Burton, JO;
Bishop, NC;
... Graham-Brown, MPM; + view all
(2021)
Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.
Kidney International
10.1016/j.kint.2021.04.008.
(In press).
|
|
|
Bjornstad, P;
Greasley, PJ;
Wheeler, DC;
Chertow, GM;
Langkilde, AM;
Heerspink, HJL;
van Raalte, DH;
(2021)
The potential roles of osmotic and non-osmotic sodium handling in mediating effects of SGLT2 inhibitors on heart failure.
Journal of Cardiac Failure
10.1016/j.cardfail.2021.07.003.
(In press).
|
|
|
Bockenhauer, D;
Kleta, R;
(2021)
Tubulopathy meets Sherlock Holmes: biochemical fingerprinting of disorders of altered kidney tubular salt handling.
Pediatric Nephrology
10.1007/s00467-021-05098-5.
(In press).
|
|
|
Boyer, O;
Schaefer, F;
Haffner, D;
Bockenhauer, D;
Holtta, T;
Berody, S;
Webb, H;
... Vivarelli, M; + view all
(2021)
Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.
Nature Reviews Nephrology
, 17
pp. 277-289.
10.1038/s41581-020-00384-1.
|
|
Buck, M;
Poirier, E;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... The Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay [version 1; peer review: 1 approved with reservations].
Wellcome Open Research
, 6
(9)
10.12688/wellcomeopenres.16517.1.
|
|
|
Buck, MD;
Poirier, EZ;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay.
Wellcome Open Research
, 6
, Article 9. 10.12688/wellcomeopenres.16517.2.
|
|
|
Caplin, B;
Ashby, D;
McCafferty, K;
Hull, R;
Asgari, E;
Ford, M;
Cole, N;
... Salama, A; + view all
(2021)
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients.
Clinical Journal of the American Society of Nephrology
, 16
(5)
, Article 03180321. 10.2215/CJN.03180321.
|
|
|
Carr, EJ;
Wu, M;
Harvey, R;
Wall, EC;
Kelly, G;
Hussain, S;
Howell, M;
... Roustan, C; + view all
(2021)
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
The Lancet
, 398
(10305)
pp. 1038-1041.
10.1016/s0140-6736(21)01854-7.
|
|
Chacko, L;
Boldrini, M;
Martone, R;
Law, S;
Martinez-Naharrro, A;
Hutt, DF;
Kotecha, T;
... Fontana, M; + view all
(2021)
Cardiac Magnetic Resonance–Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid.
Circulation: Cardiovascular Imaging
, 14
(4)
, Article e012506. 10.1161/CIRCIMAGING.121.012506.
|
|
Chertow, GM;
Vart, P;
Jongs, N;
Toto, RD;
Gorriz, JL;
Hou, FF;
McMurray, JJV;
... DAPA-CKD Trial Committees and Investigators, .; + view all
(2021)
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
Journal of the American Society of Nephrology
, 32
(9)
pp. 2352-2361.
10.1681/ASN.2021020167.
|
|
|
Cherukuri, A;
Salama, AD;
Mehta, R;
Mohib, K;
Zheng, L;
Magee, C;
Harber, M;
... Rothstein, DM; + view all
(2021)
Transitional B cell cytokines predict renal allograft outcomes.
Science Translational Medicine
, 13
(582)
10.1126/scitranslmed.abe4929.
|
|
|
Christian, MT;
Webb, NJA;
Mehta, S;
Woolley, RL;
Afentou, N;
Frew, E;
Brettell, EA;
... Ives, N; + view all
(2021)
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
JAMA Pediatrics
10.1001/jamapediatrics.2021.5189.
(In press).
|
|
|
Clarke, Sophie A;
Phylactou, Maria;
Patel, Bijal;
Mills, Edouard G;
Muzi, Beatrice;
Izzi-Engbeaya, Chioma;
Khoo, Bernard;
... Dhillo, Waljit S; + view all
(2021)
Preserved C-peptide in survivors of COVID-19: Post hoc analysis.
Diabetes, Obesity & Metabolism
, 24
(3)
pp. 570-574.
10.1111/dom.14608.
|
|
|
Clarke, SA;
Phylactou, M;
Patel, B;
Mills, EG;
Muzi, B;
Izzi-Engbeaya, C;
Choudhury, S;
... Dhillo, WS; + view all
(2021)
Normal adrenal and thyroid function in patients who survive COVID-19 infection.
Journal of Clinical Endocrinology and Metabolism
10.1210/clinem/dgab349.
(In press).
|
|
|
Davidson, SM;
Lukhna, K;
Gorog, DA;
Salama, AD;
Castillo, AR;
Giesz, S;
Golforoush, P;
... Yellon, DM; + view all
(2021)
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
[Corrigendum].
Cardiovascular Drugs and Therapy
10.1007/s10557-021-07223-w.
(In press).
|
|
Davidson, SM;
Lukhna, K;
Gorog, DA;
Salama, AD;
Castillo, AR;
Giesz, S;
Golforoush, P;
... Yellon, DM; + view all
(2021)
RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
Cardiovascular Drugs and Therapy
10.1007/s10557-021-07221-y.
(In press).
|
|
|
Downie, ML;
Gupta, S;
Tekman, MC;
Cheshire, C;
Arora, S;
Licht, C;
Robinson, LA;
... Kleta, R; + view all
(2021)
Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy.
Kidney International Reports
10.1016/j.ekir.2021.02.025.
(In press).
|
|
|
Dritsoula, A;
Kislikova, M;
Oomatia, A;
Webster, AP;
Beck, S;
Ponticos, M;
Lindsey, B;
... Caplin, B; + view all
(2021)
Epigenome-wide methylation profile of chronic kidney disease-derived arterial DNA uncovers novel pathways in disease-associated cardiovascular pathology.
Epigenetics
, 16
(7)
pp. 718-728.
10.1080/15592294.2020.1819666.
|
|
Dufek-Kamperis, S;
Kleta, R;
Bockenhauer, D;
Gale, D;
Downie, ML;
(2021)
Novel insights in the genetics of steroid-sensitive nephrotic syndrome in childhood.
Pediatric Nephrology
, 36
pp. 2165-2175.
10.1007/s00467-020-04780-4.
|
|
Ebert, T;
Qureshi, AR;
Lamina, C;
Fotheringham, J;
Froissart, M;
Eckardt, KU;
Wheeler, DC;
... Stenvinkel, P; + view all
(2021)
Time-dependent lipid profile inversely associates with mortality in hemodialysis patients – independent of inflammation/malnutrition.
Journal of Internal Medicine
10.1111/joim.13291.
|
|
|
Edwards, NC;
Price, AM;
Mehta, S;
Hiemstra, TF;
Kaur, A;
Greasley, PJ;
Webb, DJ;
... Townend, JN; + view all
(2021)
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial.
Clinical Journal of the American Society of Nephrology
, 16
(10)
pp. 1491-1501.
10.2215/CJN.01930221.
|
|
Emma, F;
Hoff, WV;
Hohenfellner, K;
Topaloglu, R;
Greco, M;
Ariceta, G;
Bettini, C;
... Levtchenko, E; + view all
(2021)
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Kidney International
, 100
(5)
pp. 1112-1123.
10.1016/j.kint.2021.06.019.
|
|
Evangelidis, N;
Sautenet, B;
Madero, M;
Tong, A;
Ashuntantang, G;
Sanabria, LC;
de Boer, IH;
... Craig, JC; + view all
(2021)
Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy.
Trials
, 22
(1)
, Article 612. 10.1186/s13063-021-05574-1.
|
|
|
Evangelidis, N;
Sautenet, B;
Manera, KE;
Howell, M;
Craig, JC;
Viecelli, AK;
O'Lone, E;
... SONG-HD and SONG-PD initiative; + view all
(2021)
Perspectives on blood pressure by patients on haemo- and peritoneal dialysis.
Nephrology
, 26
(1)
pp. 62-69.
10.1111/nep.13775.
|
|
Evans, RDR;
Smyth, B;
Levin, A;
Jha, V;
Wheeler, DC;
Jardine, M;
Perkovic, V;
... Hiemstra, T; + view all
(2021)
The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals.
Kidney International
, 99
(3)
pp. 551-554.
10.1016/j.kint.2020.10.048.
|
|
Faulkner, N;
Ng, KW;
Wu, MY;
Harvey, R;
Margaritis, M;
Paraskevopoulou, S;
Houlihan, C;
... Kassiotis, G; + view all
(2021)
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains.
eLife
, 10
, Article e69317. 10.7554/eLife.69317.
|
|
|
Fendler, A;
Shepherd, STC;
Au, L;
Wilkinson, KA;
Wu, M;
Schmitt, AM;
Tippu, Z;
... CAPTURE consortium, .; + view all
(2021)
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
10.1016/j.ccell.2021.12.013.
(In press).
|
|
|
Fotheringham, J;
Latimer, N;
Froissart, M;
Kronenberg, F;
Stenvinkel, P;
Floege, J;
Eckardt, K-U;
(2021)
Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study.
Clinical Kidney Journal
, 14
(2)
pp. 665-672.
10.1093/ckj/sfaa250.
|
|
|
Gauckler, P;
Shin, JI;
Alberici, F;
Audard, V;
Bruchfeld, A;
Busch, M;
Cheung, CK;
... Kronbichler, A; + view all
(2021)
Rituximab in Membranous Nephropathy.
Kidney International Reports
10.1016/j.ekir.2020.12.035.
(In press).
|
|
|
Gibson, J;
Fieldhouse, R;
Chan, MMY;
Sadeghi-Alavijeh, O;
Burnett, L;
Izzi, V;
Persikov, AV;
... Savige, J; + view all
(2021)
Prevalence estimates of predicted pathogenic col4a3-col4a5 variants in a population sequencing database and their implications for alport syndrome.
Journal of the American Society of Nephrology
, 32
(9)
pp. 2273-2290.
10.1681/ASN.2020071065.
|
|
|
Gill, K;
Horsley, H;
Swamy, S;
Khasriya, R;
Malone-Lee, J;
(2021)
A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome.
BMC Urology
, 21
(1)
, Article 39. 10.1186/s12894-021-00809-4.
|
|
|
Greenan-Barrett, J;
Doolan, G;
Shah, D;
Virdee, S;
Robinson, G;
Choida, V;
Gak, N;
... Ciurtin, C; + view all
(2021)
Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus.
International Journal of Molecular Sciences
, 22
(14)
, Article 7619. 10.3390/ijms22147619.
|
|
Greenwood, SA;
Koufaki, P;
Macdonald, J;
Bhandari, S;
Burton, J;
Dasgupta, I;
Farrington, K;
... Mercer, TH; + view all
(2021)
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial.
Clinical Kidney Journal
, 14
(5)
pp. 1345-1355.
10.1093/ckj/sfaa107.
|
|
|
Greenwood, SA;
Koufaki, P;
Macdonald, JH;
Bhandari, S;
Burton, JO;
Dasgupta, I;
Farrington, K;
... Mercer, TH; + view all
(2021)
Randomized Trial—PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving Hemodialysis.
Kidney International Reports
10.1016/j.ekir.2021.05.034.
(In press).
|
|
|
Greenwood, SA;
Koufaki, P;
Macdonald, JH;
Bulley, C;
Bhandari, S;
Burton, JO;
Dasgupta, I;
... Mercer, TH; + view all
(2021)
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT.
Health Technology Assessment
, 25
(40)
10.3310/hta25400.
|
|
|
Haschler, TN;
Horsley, H;
Balys, M;
Anderson, G;
Taanman, JW;
Unwin, RJ;
Norman, JT;
(2021)
Sirtuin 5 depletion impairs mitochondrial function in human proximal tubular epithelial cells.
Scientific Reports
, 11
(1)
, Article 15510. 10.1038/s41598-021-94185-6.
|
|
|
Hayes, AR;
Mak, IYF;
Evans, N;
Naik, R;
Crawford, A;
Khoo, B;
Grossman, AB;
... Meyer, T; + view all
(2021)
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.
Neuroendocrinology
, 111
(9)
pp. 863-875.
10.1159/000511662.
|
|
Heerspink, HJ;
Cherney, D;
Postmus, D;
Stefánsson, BV;
Chertow, GM;
Dwyer, JP;
Greene, T;
... DAPA-CKD trial committees and investigators; + view all
(2021)
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Kidney International
10.1016/j.kint.2021.09.005.
(In press).
|
|
|
Heerspink, HJL;
Jongs, N;
Chertow, GM;
Langkilde, AM;
McMurray, JJV;
Correa-Rotter, R;
Rossing, P;
... DAPA-CKD Trial Committees and Investigators, .; + view all
(2021)
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Lancet Diabetes Endocrinol
, 9
(11)
pp. 743-754.
10.1016/S2213-8587(21)00242-4.
|
|
Heerspink, HJL;
Langkilde, A-M;
Wheeler, DC;
(2021)
Dapagliflozin in Patients with Chronic Kidney Disease.
New England Journal of Medicine
, 384
(4)
pp. 389-390.
10.1056/NEJMc2032809.
|
|
Heerspink, HJL;
Sjöström, CD;
Jongs, N;
Chertow, GM;
Kosiborod, M;
Hou, FF;
McMurray, JJV;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
European Heart Journal
, 42
(13)
pp. 1216-1227.
10.1093/eurheartj/ehab094.
|
|
|
Hellewell, J;
Russell, TW;
SAFER Investigators and Field Study Team, ,;
Crick COVID-19 Consortium, ,;
CMMID COVID-19 working group, ,;
Beale, R;
Kelly, G;
... Kucharski, AJ; + view all
(2021)
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections.
BMC Medicine
, 19
(1)
, Article 106. 10.1186/s12916-021-01982-x.
|
|
|
Huerga Encabo, H;
Grey, W;
Garcia-Albornoz, M;
Wood, H;
Ulferts, R;
Aramburu, IV;
Kulasekararaj, AG;
... Bonnet, D; + view all
(2021)
Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients.
Stem Cell Reports
10.1016/j.stemcr.2021.02.001.
(In press).
|
|
|
Ishida, JH;
Chauhan, C;
Gillespie, B;
Gruchalla, K;
McCullough, PA;
Quella, S;
Romero, A;
... Herzog, CA; + view all
(2021)
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.
Clinical Journal of the American Society of Nephrology
, 16
(5)
10.2215/CJN.17561120.
|
|
|
Islam, S;
Tekman, M;
Flanagan, SE;
Guay-Woodford, L;
Hussain, K;
Ellard, S;
Kleta, R;
... Iancu, D; + view all
(2021)
Founder mutation in the PMM2 promotor causes hyperinsulinemic hypoglycaemia/polycystic kidney disease (HIPKD).
Molecular Genetics & Genomic Medicine
, Article e1674. 10.1002/mgg3.1674.
(In press).
|
|
|
Jardine, M;
Zhou, Z;
Lambers Heerspink, HJ;
Hockham, C;
Li, Q;
Agarwal, R;
Bakris, GL;
... Perkovic, V; + view all
(2021)
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
Clinical Journal of the American Society of Nephrology
, 16
(2)
, Article 15260920. 10.2215/CJN.15260920.
|
    |
|
Jhund, PS;
Petrie, MC;
Robertson, M;
Mark, PB;
MacDonald, MR;
Connolly, E;
Anker, SD;
... PIVOTAL Investigators and Committees, .; + view all
(2021)
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy.
JACC: Heart Failure
, 9
(7)
pp. 518-527.
10.1016/j.jchf.2021.04.005.
|
|
Jongs, N;
Greene, T;
Chertow, GM;
McMurray, JJV;
Langkilde, AM;
Correa-Rotter, R;
Rossing, P;
... DAPA-CKD Trial Committees and Investigators, .; + view all
(2021)
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Lancet Diabetes and Endocrinology
, 9
(11)
pp. 755-766.
10.1016/S2213-8587(21)00243-6.
|
|
King, C;
Druce, KL;
Nightingale, P;
Kay, E;
Basu, N;
Salama, AD;
Harper, L;
(2021)
Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: A Systematic review and meta-analysis.
Rheumatology Advances in Practice
, 5
(3)
, Article rkab018. 10.1093/rap/rkab018.
|
|
|
Klionsky, DJ;
Abdel-Aziz, AK;
Abdelfatah, S;
Abdellatif, M;
Abdoli, A;
Abel, S;
Abeliovich, H;
... Taylor, A; + view all
(2021)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy
, 17
(1)
pp. 1-382.
10.1080/15548627.2020.1797280.
|
|
Konrad, M;
Nijenhuis, T;
Ariceta, G;
Bertholet-Thomas, A;
Calo, LA;
Capasso, G;
Emma, F;
... Bockenhauer, D; + view all
(2021)
Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders.
Kidney International
, 99
(2)
pp. 324-335.
10.1016/j.kint.2020.10.035.
|
|
|
Lalayiannis, AD;
Crabtree, NJ;
Ferro, CJ;
Askiti, V;
Mitsioni, A;
Biassoni, L;
Kaur, A;
... Shroff, R; + view all
(2021)
Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.
Nephrology Dialysis Transplantation
, 36
(10)
pp. 1872-1881.
10.1093/ndt/gfaa199.
|
|
Law, S;
Cohen, O;
Lachmann, H;
Rezk, T;
Gilbertson, J;
Rowczenio, D;
Wechalekar, A;
... Gillmore, J; + view all
(2021)
Renal Transplant Outcomes in Amyloidosis.
Nephrology Dialysis Transplantation
, 36
(2)
pp. 355-365.
10.1093/ndt/gfaa293.
|
|
Li, D;
Liu, M;
Li, Z;
Zheng, G;
Chen, A;
Zhao, L;
Yang, P;
... Ruan, XZ; + view all
(2021)
Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice.
Aging and Disease
, 12
(3)
pp. 747-763.
10.14336/AD.2020.1120.
|
|
|
Lu, J;
Chen, PP;
Zhang, JX;
Li, XQ;
Wang, GH;
Yuan, BY;
Huang, SJ;
... Ma, KL; + view all
(2021)
GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Theranostics
, 11
(10)
pp. 4728-4742.
10.7150/thno.56598.
|
|
|
Luo, X;
Zheng, E;
Wei, L;
Zeng, H;
Qin, H;
Zhang, X;
Liao, M;
... Chen, Y; + view all
(2021)
The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.
Cell Death & Disease
, 12
(4)
, Article 328. 10.1038/s41419-021-03596-w.
|
|
|
Mark, Patrick B;
Jhund, Pardeep S;
Walters, Matthew R;
Petrie, Mark C;
Power, Albert;
White, Claire;
Robertson, Michele;
... Ford, Ian; + view all
(2021)
Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial.
Kidney360
, 2
(11)
pp. 1761-1769.
10.34067/KID.0004272021.
|
|
McGlone, ER;
Malallah, K;
Cuenco, J;
Wewer Albrechtsen, NJ;
Holst, JJ;
Vincent, RP;
Ling, C;
... Tan, TMM; + view all
(2021)
Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study.
AJP - Endocrinology and Metabolism
, 320
(4)
E671-E679.
10.1152/ajpendo.00580.2020.
|
|
McMurray, JJV;
Wheeler, DC;
Stefánsson, BV;
Jongs, N;
Postmus, D;
Correa-Rotter, R;
Chertow, GM;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure.
JACC: Heart Failure
10.1016/j.jchf.2021.06.017.
(In press).
|
|
|
McMurray, JJV;
Wheeler, DC;
Stefánsson, BV;
Jongs, N;
Postmus, D;
Correa-Rotter, R;
Chertow, GM;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.
Circulation
, 143
(5)
pp. 438-448.
10.1161/CIRCULATIONAHA.120.051675.
|
|
Mingrone, Geltrude;
van Baar, Annieke CG;
Deviere, Jacques;
Hopkins, David;
Moura, Eduardo;
Cercato, Cintia;
Rajagopalan, Harith;
... Bergman, JJGHM; + view all
(2021)
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.
GUT
, 71
(2)
pp. 254-264.
10.1136/gutjnl-2020-323608.
|
|
Mueller, Roman-Ulrich;
Messchendorp, A Lianne;
Birn, Henrik;
Capasso, Giovambattista;
Cornec-Le Gall, Emilie;
Devuyst, Olivier;
van Eerde, Albertien;
... Gansevoort, Ron T; + view all
(2021)
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.
Nephrology Dialysis Transplantation
10.1093/ndt/gfab312.
(In press).
|
|
|
Muir, L;
Jaffer, A;
Rees-Spear, C;
Gopalan, V;
Chang, F;
Fernando, R;
Vaitkute, G;
... Motallebzadeh, R; + view all
(2021)
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.
Kidney International Reports
10.1016/j.ekir.2021.03.902.
(In press).
|
|
|
Murray, BO;
Flores, C;
Williams, C;
Flusberg, DA;
Marr, EE;
Kwiatkowska, KM;
Charest, JL;
... Rohn, JL; + view all
(2021)
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems.
Frontiers in Cellular and Infection Microbiology
, 11
, Article ARTN 691. 10.3389/fcimb.2021.691210.
|
|
|
Neradova, A;
Vajgel, G;
Hendra, H;
Antonelou, M;
Kostakis, ID;
Wright, D;
Masson, P;
... Burns, Á; + view all
(2021)
Frailty score before admission as risk factor for mortality of renal patients during the first wave of the COVID pandemic in London.
Giornale Italiano di Nefrologia
, 38
(3)
pp. 1-8.
|
|
Neuen, BL;
Ohkuma, T;
Neal, B;
Matthews, DR;
de Zeeuw, D;
Mahaffey, KW;
Fulcher, G;
... Wheeler, DC; + view all
(2021)
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
American Journal of Kidney Diseases
, 77
(1)
23-34.e1.
10.1053/j.ajkd.2020.06.018.
|
|
Neuen, BL;
Oshima, M;
Perkovic, V;
Agarwal, R;
Arnott, C;
Bakris, G;
Cannon, CP;
... Heerspink, HJL; + view all
(2021)
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
European Heart Journal
, 42
(48)
pp. 4891-4901.
10.1093/eurheartj/ehab497.
|
|
Niemi, MEK;
Karjalainen, J;
Liao, RG;
Neale, BM;
Daly, M;
Ganna, A;
Pathak, GA;
... Donohue, C; + view all
(2021)
Mapping the human genetic architecture of COVID-19.
Nature
, 600
pp. 472-477.
10.1038/s41586-021-03767-x.
|
|
|
Pairo-Castineira, E;
Clohisey, S;
Klaric, L;
Bretherick, AD;
Rawlik, K;
Pasko, D;
Walker, S;
... Baillie, JK; + view all
(2021)
Genetic mechanisms of critical illness in COVID-19.
Nature
, 591
pp. 92-98.
10.1038/s41586-020-03065-y.
|
|
Papa, R;
Lane, T;
Minden, K;
Touitou, I;
Cantarini, L;
Cattalini, M;
Obici, L;
... Pediatric Rheumatology International Trials Organization (PRINTO; + view all
(2021)
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry.
The Journal of Allergy and Clinical Immunology: In Practice
, 9
(2)
783-791.e4.
10.1016/j.jaip.2020.10.053.
|
|
Patel, V;
Klootwijk, E;
Whiting, G;
Bockenhauer, D;
Siew, K;
Walsh, S;
Bleich, M;
... Wheeler, J; + view all
(2021)
Quantification of FAM20A in human milk and identification of calcium metabolism proteins.
Physiological Reports
, 9
(24)
, Article e15150. 10.14814/phy2.15150.
|
|
|
Pecoits-Filho, R;
James, G;
Carrero, JJ;
Wittbrodt, E;
Fishbane, S;
Sultan, AA;
Heerspink, HJL;
... Wheeler, DC; + view all
(2021)
Methods and rationale of the DISCOVER CKD global observational study.
Clinical Kidney Journal
, 14
(6)
pp. 1570-1578.
10.1093/ckj/sfab046.
|
|
|
Perkovic, V;
Blackorby, A;
Cizman, B;
Carroll, K;
Cobitz, AR;
Davies, R;
DiMino, TL;
... Singh, AK; + view all
(2021)
The ASCEND-ND trial: Study design and participant characteristics.
Nephrology Dialysis Transplantation
10.1093/ndt/gfab318.
(In press).
|
|
|
Persson, F;
Rossing, P;
Vart, P;
Chertow, GM;
Hou, FF;
Jongs, N;
McMurray, JJV;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial.
Diabetes Care
, 44
(6)
, Article dc210300. 10.2337/dc21-0300.
|
|
Petrie, MC;
Jhund, PS;
Connolly, E;
Mark, PB;
MacDonald, MR;
Robertson, M;
Anker, SD;
... PIVOTAL Investigators and Committees; + view all
(2021)
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis.
Cardiovascular Research
10.1093/cvr/cvab317.
(In press).
|
|
Poirier, EZ;
Buck, MD;
Chakravarty, P;
Carvalho, J;
Frederico, B;
Cardoso, A;
Healy, L;
... e Sousa, CR; + view all
(2021)
An isoform of Dicer protects mammalian stem cells against multiple RNA viruses.
Science
, 373
(6551)
pp. 231-236.
10.1126/science.abg2264.
|
|
|
Poo, SX;
Pepper, RJ;
Onwordi, L;
Ghufoor, K;
Sandhu, G;
Salama, AD;
(2021)
Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G4-related disease.
Scandinavian Journal of Rheumatology
, 50
(1)
pp. 52-57.
10.1080/03009742.2020.1777324.
|
|
Price, E;
Allen, A;
Rauz, S;
Tappuni, A;
Sutcliffe, N;
Bombardieri, M;
Carty, S;
... Bowman, S; + view all
(2021)
The management of Sjögren's syndrome: British Society for Rheumatology guideline scope.
Rheumatology
, 60
(5)
pp. 2122-2127.
10.1093/rheumatology/keaa870.
|
|
Raby, KL;
Horsely, H;
McCarthy-Boxer, A;
Norman, JT;
Wilson, PD;
(2021)
Urinary exosome proteomic profiling defines stage-specific rapid progression of Autosomal Dominant Polycystic Kidney Disease and Tolvaptan efficacy.
BBA Advances
, Article 100013. 10.1016/j.bbadva.2021.100013.
(In press).
|
|
|
Randles, MJ;
Lausecker, F;
Kong, Q;
Suleiman, H;
Reid, G;
Kolatsi-Joannou, M;
Davenport, B;
... Lennon, R; + view all
(2021)
Identification of an altered matrix signature in kidney ageing and disease.
Journal of the American Society of Nephrology
, 32
(7)
pp. 1713-1732.
10.1681/ASN.2020101442.
|
|
RECOVERY Collaborative Group;
(2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
The Lancet
, 397
(10289)
pp. 2049-2059.
10.1016/S0140-6736(21)00897-7.
|
|
|
RECOVERY Collaborative Group, .;
(2021)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet
, 397
(10274)
pp. 605-612.
10.1016/S0140-6736(21)00149-5.
|
|
|
Rezk, T;
Fontana, M;
Gillmore, JD;
(2021)
A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis.
Expert Opinion on Orphan Drugs
, 9
(3)
10.1080/21678707.2021.1898371.
|
|
|
Rezk, T;
Salota, R;
Gan, JJ;
Lachmann, HJ;
Fontana, M;
Siew, K;
Martinez-Naharro, A;
... Gillmore, JD; + view all
(2021)
Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
British Journal of Haematology
10.1111/bjh.17706.
|
|
|
Riedhammer, KM;
Schmaderer, C;
Heemann, U;
Bockenhauer, D;
(2021)
Tubulopathies.
Der Nephrologe
, 16
(6)
pp. 397-410.
10.1007/s11560-021-00547-6.
|
|
Rosa, A;
Pye, VE;
Graham, C;
Muir, L;
Seow, J;
Ng, KW;
Cook, NJ;
... Cherepanov, P; + view all
(2021)
SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity.
Science Advances
10.1126/sciadv.abg7607.
(In press).
|
|
|
Rutherford, MA;
Scott, J;
Karabayas, M;
Antonelou, M;
Gopaluni, S;
Gray, D;
Barrett, J;
... UKIVAS; + view all
(2021)
Risk factors for severe outcomes in patients with systemic vasculitis & COVID‐19: a bi‐national registry‐based cohort study.
Arthritis & Rheumatology
10.1002/art.41728.
(In press).
|
|
|
Santos, M;
Pereira, SB;
Flores, C;
Príncipe, C;
Couto, N;
Karunakaran, E;
Cravo, SM;
... Tamagnini, P; + view all
(2021)
Absence of KpsM (Slr0977) Impairs the Secretion of Extracellular Polymeric Substances (EPS) and Impacts Carbon Fluxes in Synechocystis sp. PCC 6803.
mSphere
, 6
(1)
, Article e00003-21. 10.1128/msphere.00003-21.
|
|
|
Sarraju, A;
Li, J;
Cannon, CP;
Chang, TI;
Agarwal, R;
Bakris, G;
Charytan, DM;
... Mahaffey, KW; + view all
(2021)
Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial.
American Heart Journal
, 233
pp. 141-148.
10.1016/j.ahj.2020.12.008.
|
|
Schlingmann, KP;
Renigunta, A;
Hoorn, EJ;
Forst, A-L;
Renigunta, V;
Atanasov, V;
Mahendran, S;
... Konrad, M; + view all
(2021)
Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural Deafness.
Journal of the American Society of Nephrology
, 32
(5)
10.1681/ASN.2020111587.
|
|
Scott, J;
Canepa, C;
Buettner, A;
Ryan, L;
Moloney, B;
Cormican, S;
Walsh, C;
... Little, MA; + view all
(2021)
A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes.
Scientific Reports
, 11
, Article 13080. 10.1038/s41598-021-92629-7.
|
|
|
Singh, AK;
Carroll, K;
McMurray, JJ;
Solomon, S;
Jha, V;
Johansen, KL;
Lopes, RD;
... Perkovic, V; + view all
(2021)
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
The New England Journal of Medicine
, 385
pp. 2313-2324.
10.1056/NEJMoa2113380.
|
|
Singh, AK;
Carroll, K;
Perkovic, V;
Solomon, S;
Jha, V;
Johansen, KL;
Lopes, RD;
... McMurray, JJ; + view all
(2021)
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
New England Journal of Medicine
, 385
pp. 2325-2335.
10.1056/NEJMoa2113379.
|
|
Singh, AK;
Blackorby, A;
Cizman, B;
Carroll, K;
Cobitz, AR;
Davies, R;
Jha, V;
... Wiecek, A; + view all
(2021)
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Nephrology Dialysis Transplantation
10.1093/ndt/gfab065.
(In press).
|
|
|
Stefánsson, BV;
Heerspink, HJL;
Wheeler, DC;
Sjöström, CD;
Greasley, PJ;
Sartipy, P;
Cain, V;
(2021)
Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline.
Data Brief
, 37
, Article 107237. 10.1016/j.dib.2021.107237.
|
|
|
Stubbs, MJ;
Coppo, P;
Cheshire, C;
Veyradier, A;
Dufek, S;
Levine, AP;
Thomas, M;
... Scully, MA; + view all
(2021)
Identification of a novel genetic locus associated with immune mediated thrombotic thrombocytopenic purpura.
Haematologica
10.3324/haematol.2020.274639.
(In press).
|
|
|
Tam, AYY;
Horwell, AL;
Trinder, SL;
Khan, K;
Xu, S;
Ong, V;
Denton, CP;
... Abraham, DJ; + view all
(2021)
Selective deletion of Connective Tissue Growth Factor attenuates experimentally -induced pulmonary fibrosis and pulmonary arterial hypertension.
The International Journal of Biochemistry & Cell Biology
, Article 105961. 10.1016/j.biocel.2021.105961.
(In press).
|
|
Tan, TM-M;
Minnion, J;
Khoo, B;
Ball, L-J;
Malviya, R;
Day, E;
Fiorentino, F;
... Bloom, SR; + view all
(2021)
Safety and Efficacy of an Extended-Release Peptide YY Analogue for Obesity: a Randomised, Placebo-Controlled, Phase 1 Trial.
Diabetes, Obesity and Metabolism
, 23
(7)
pp. 1471-1483.
10.1111/dom.14358.
|
|
|
Tandogdu, Z;
Collins, J;
Shaw, G;
Rohn, J;
Koves, B;
Sachdeva, A;
Ghazi, A;
... Kelly, J; + view all
(2021)
Management of patients who opt for radical prostatectomy during the COVID‐19 pandemic: An International Accelerated Consensus Statement.
BJU International
, 127
(6)
pp. 729-741.
10.1111/bju.15299.
|
|
Trepiccione, F;
Walsh, SB;
Ariceta, G;
Boyer, O;
Emma, F;
Camilla, R;
Ferraro, PM;
... Bockenhauer, D; + view all
(2021)
Distal renal tubular acidosis: ERKNet/ESPN clinical practice points.
Nephrology Dialysis Transplantation
, 36
(9)
pp. 1585-1596.
10.1093/ndt/gfab171.
|
|
Ulferts, R;
Marcassa, E;
Timimi, L;
Lee, LC;
Daley, A;
Montaner, B;
Turner, SD;
... Beale, R; + view all
(2021)
Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation.
Cell Reports
, 37
(4)
, Article 109899. 10.1016/j.celrep.2021.109899.
|
|
|
Viering, D;
Schlingmann, K-P;
Hureaux, M;
Nijenhuis, T;
Mallett, A;
Chan, MMY;
van Beek, A;
... de Baaij, J; + view all
(2021)
Gitelman-like syndrome caused by pathogenic variants in mtDNA.
Journal of the American Society of Nephrology : JASN
(In press).
|
 |
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DL; + view all
(2021)
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
The Lancet
10.1016/S0140-6736(21)01462-8.
(In press).
|
|
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DLV; + view all
(2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
The Lancet
10.1016/s0140-6736(21)01290-3.
(In press).
|
|
|
Wan, ER;
Siew, K;
Heptinstall, L;
Walsh, SB;
(2021)
Fumaric acid ester–induced renal Fanconi syndrome: evidence of mitochondrial toxicity.
Clinical Kidney Journal
, Article sfaa270. 10.1093/ckj/sfaa270.
(In press).
|
|
|
Wan, ER;
Unwin, R;
Walsh, SB;
(2021)
COVID-19 2020: The Experience of a London Teaching Hospital's Nephrology Service.
Kidney and Blood Pressure Research
, 46
(2)
pp. 137-141.
10.1159/000515194.
|
|
|
Wheeler, DC;
(2021)
Chlorthalidone in Advanced Chronic Kidney Disease - Have We Missed a Trick?
New England Journal of Medicine
, 385
(27)
pp. 2574-2575.
10.1056/NEJMe2118149.
|
|
Wheeler, DC;
Jongs, N;
Stefansson, BV;
Chertow, GM;
Greene, T;
Hou, FF;
Langkilde, AM;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: A prespecified analysis of the DAPA-CKD trial.
Nephrology Dialysis Transplantation
10.1093/ndt/gfab335.
(In press).
|
|
|
Wheeler, DC;
Stefansson, B;
Jongs, N;
Chertow, GM;
Greene, T;
Hou, FF;
McMurray, JJ;
... Heerspink, HJL; + view all
(2021)
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
Lancet Diabetes & Endocrinology
, 9
(1)
pp. 22-31.
10.1016/S2213-8587(20)30369-7.
|
|
Wheeler, DC;
Toto, RD;
Stefansson, BV;
Jongs, N;
Chertow, GM;
Greene, T;
Hou, FF;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
Kidney International
10.1016/j.kint.2021.03.033.
(In press).
|
|
|
Wijkström, Julia;
Gonzalez-Quiroz, Marvin;
Leiva, Ricardo;
Trujillo, Zulma Cruz;
Elinder, Carl-Gustaf;
Wernerson, Annika;
(2021)
Mesoamerican Nephropathy and Kidney Disease Progression: A Case Series of Individuals With Kidney Biopsies From Nicaragua and El Salvador.
Kidney Medicine
, 3
(5)
pp. 871-873.
10.1016/j.xkme.2021.04.016.
|
|
Wong, EKS;
Marchbank, KJ;
Lomax-Browne, H;
Pappworth, IY;
Denton, H;
Cooke, K;
Ward, S;
... MPGN/DDD/C3 Glomerulopathy Rare Disease Group and National Study; + view all
(2021)
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Clinical Journal of the American Society of Nephrology (CJASN)
, 16
(11)
pp. 1639-1651.
10.2215/CJN.00320121.
|
|
|
Wong, MG;
Lv, J;
Hladunewich, MA;
Jha, V;
Hooi, LS;
Monaghan, H;
Zhao, M;
... TESTING Study Group; + view all
(2021)
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
American Journal of Nephrology
pp. 1-10.
10.1159/000519812.
|
|
|
Wu, JG-A;
Tong, A;
Evangelidis, N;
Manera, KE;
Hanson, CS;
Baumgart, A;
Amir, N;
... Craig, JC; + view all
(2021)
Patient and caregiver perspectives on blood pressure in children with chronic kidney disease.
Nephrology Dialysis Transplantation
, 37
(7)
pp. 1330-1339.
10.1093/ndt/gfab194.
|
|
Ye, N;
Jardine, MJ;
Oshima, M;
Hockham, C;
Heerspink, HJL;
Agarwal, R;
Bakris, G;
... Neuen, BL; + view all
(2021)
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights from the CREDENCE Trial.
Circulation
, 143
(18)
pp. 1735-1749.
10.1161/CIRCULATIONAHA.120.048740.
|
|
Zeng, J;
Weissmann, F;
Bertolin, AP;
Posse, V;
Canal, B;
Ulferts, R;
Wu, M;
... Diffley, JFX; + view all
(2021)
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Biochemical Journal
, 478
(13)
pp. 2405-2423.
10.1042/BCJ20210201.
|
|
|
Zhao, L;
Li, Y;
Ding, Q;
Li, Y;
Chen, Y;
Ruan, XZ;
(2021)
CD36 Senses Dietary Lipids and Regulates Lipids Homeostasis in the Intestine.
Frontiers in Physiology
, 12
, Article 669279. 10.3389/fphys.2021.669279.
|
|
|
Zhou, C;
He, Q;
Gan, H;
Zeng, T;
Liu, Q;
Moorhead, JF;
Varghese, Z;
... Ruan, XZ; + view all
(2021)
Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans.
Kidney International
, 99
(6)
pp. 1342-1353.
10.1016/j.kint.2021.01.016.
|
Conference item
|
Bockenhauer, D;
Emma, F;
Talhi, A;
Papizh, S;
Atmis, B;
Homan, N;
Aksu, B;
... Topologlu, R; + view all
(2021)
The European dRTA Registry: an initial data analysis.
Presented at: 58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA).
|
 |
|
Cardoza, Kathryn;
Kang, Amy;
Smyth, Brendan;
Yi, Tae Won;
Di Tanna, Gian Luca;
Pollock, Carol A;
De Zeeuw, Dick;
... Mahaffey, Kenneth W; + view all
(2021)
133-LB: Canagliflozin Improves Cardiovascular and Renal Outcomes across Broad Geographic Regions: Results from CREDENCE.
Presented at: 81st Scientific Sessions, Virtual.
|
|
Liao, Jinlan;
Kang, Amy;
Xia, Chao;
Arnott, Clare;
Di Tanna, Gian Luca;
Krishnan, Arun V;
Pollock, Carol A;
... Smyth, Brendan; + view all
(2021)
131-LB: The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial.
Presented at: 81st Scientific Sessions, Virtual.
|
|
Muir, L;
Jaffer, A;
Rees-Spear, C;
Gopalan, V;
Chang, F;
Vaitkute, G;
Fernando, R;
... Motallebzadeh, R; + view all
(2021)
Profile of SARS-CoV-2 Antibodies in Patients Awaiting Kidney Transplantation.
Presented at: 2021 American Transplant Congress, Virtual conference.
|
|
|
Persson, Frederik;
Rossing, Peter;
Vart, Priya;
Chertow, Glenn M;
Hou, Fan Fan;
McMurray, John J;
Correa-Rotter, Ricardo;
... Heerspink, Hiddo L; + view all
(2021)
317-OR: Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial.
Presented at: 81st Virtual Scientific Sessions, Virtual.
|
|
Rossing, Peter;
Vart, Priya;
Chertow, Glenn M;
Hou, Fan Fan;
Jongs, Niels;
Mcmurray, John J;
Correa-Rotter, Ricardo;
... Heerspink, Hiddo L; + view all
(2021)
130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease.
Presented at: 81st Scientific Sessions, Virtual.
|
|
Yi, Tae Won;
Smyth, Brendan;
Kang, Amy;
Cardoza, Kathryn;
Di Tanna, Gian Luca;
Arnott, Clare;
Pollock, Carol A;
... Jardine, Meg J; + view all
(2021)
129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial.
Presented at: 81st Scientific Sessions, Virtual.
|
